Bone mineral density change in type 1 Gaucher disease adults given velaglucerase alfa for 2 years

被引：1
|
作者：
Zimran, An [1 ,2 ]
Giraldo, Pilar [3 ,4 ]
Zahrieh, David [5 ]
Crombez, Eric [5 ]
Cohn, Gabriel [5 ]
Elstein, Deborah [1 ,2 ]
机构：
[1] Shaare Zedek Med Ctr, Gaucher Clin, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
[3] CIBERER, Zaragoza, Spain
[4] Hosp Univ Miguel Servet, Zaragoza, Spain
[5] Shire Human Genet Therapies Inc, Lexington, MA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2013年 / 108卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2012.11.279
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
265
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [1] Bone mineral density change in type 1 Gaucher disease adults given velaglucerase alfa for 2 years (vol 108, pg S101, 2013)
    Zimran, Ari
    Giraldo, Pilar
    Zahrieh, David
    Crombez, Eric
    Cohn, Gabriel
    Elstein, Deborah
    MOLECULAR GENETICS AND METABOLISM, 2013, 109 (01) : 119 - 119
  • [2] Velaglucerase Alfa for the Management of Type 1 Gaucher Disease
    Morris, Jennifer L.
    CLINICAL THERAPEUTICS, 2012, 34 (02) : 259 - 271
  • [3] BONE MINERAL DENSITY IN ADULTS WITH TYPE 1 GAUCHER DISEASE RECEIVING VELAGLUCERASE ALFA 60 U/KG EVERY OTHER WEEK: 2-YEAR RESULTS
    Elstein, D.
    Ben Turkia, H.
    Gonzalez, D. E.
    Kabra, M.
    Lukina, E. A.
    Giraldo, P.
    Kisinovsky, I
    Bavdekar, A.
    Ben Dridi, M-F
    Gupta, N.
    Kishnani, P. S.
    Mehta, A.
    Zahrieh, D.
    Hangartner, T. N.
    Crombez, E.
    Zimran, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S150 - S150
  • [4] Rapid intravenous infusion of velaglucerase-alfa in adults with type 1 Gaucher disease
    Zimran, Ari
    Revel-Vilk, Shoshana
    Becker-Cohen, Michal
    Chicco, Gaya
    Arbel, Naama
    Rolfs, Arndt
    Szer, Jeff
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E246 - E248
  • [5] BONE MINERAL DENSITY RESPONSE TO ENZYME REPLACEMENT THERAPY OVER 2 YEARS IN ADULTS WITH TYPE 1 GAUCHER DISEASE
    Zimran, A.
    Gonzalez, D. E.
    Kabra, M.
    Lukina, E. A.
    Giraldo, P.
    Kisinovsky, I
    Bavdekar, A.
    Ben Dridi, M-F
    Gupta, N.
    Kishnani, P. S.
    Mehta, A.
    Elstein, D.
    Wang, N.
    Hangartner, T. N.
    Crombez, E.
    Ben Turkia, H.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S149 - S149
  • [6] Achievement of Therapeutic Goals Over 2 Years of Velaglucerase Alfa Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease
    Elstein, Deborah
    Ben Turkia, Hadhami
    Kabra, Madhulika
    Giraldo, Pilar
    Ben Dridi, Marie-Francoise
    Gupta, Neerja
    Zahrieh, David
    Crombez, Eric
    Zimran, Ari
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S28 - S28
  • [7] Safety and efficacy of velaglucerase alfa replacement therapy for patients with type 1 Gaucher disease
    Elstein, Deborah
    Zimran, Ari
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (04) : 333 - 339
  • [8] Home infusion therapy with velaglucerase alfa for Gaucher disease type 1 in Germany and Austria
    Mengel, Eugen
    Stulnig, Thomas M.
    Kralewski, Martina
    Lachmann, Anja
    Martus, Pater
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S109 - S109
  • [9] Bone mineral density improvements in velaglucerase alfa-treated patients with Gaucher disease: Real-world data from the Gaucher Outcome Survey (GOS)
    Zimrana, Ari
    Botha, Jaco
    Eastellc, Richard
    Ficicioglud, Can
    Finkelmane, Richard D.
    Frydmana, Dafna
    Giraldof, Pilar
    Goker-Alpang, Ozlem
    Kishnanih, Priya S.
    Laui, Heather A.
    Ruhrman-Shaharj, Noa
    Hughesk, Derralynn
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02)
  • [10] Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction
    Elstein, Deborah
    Foldes, A. Joseph
    Zahrieh, David
    Cohn, Gabriel M.
    Djordjevic, Maja
    Brutaru, Costin
    Zimran, Ari
    BLOOD CELLS MOLECULES AND DISEASES, 2011, 47 (01) : 56 - 61
12345